Shiga toxin-producing E. coli (STEC) O157 is easily detected using the stool cultures currently performed...

CENTOGENE is excited to announce their latest scientific publication in The Lancet Neurology – demonstrating...

Genomind is committed to empowering healthcare providers like you to provide hope through personalized care.

Join Techlab Webinar on 28 August as Dr. Snyder, Ph.D. will provide a comprehensive overview of C. difficile diagnostic testing...

Genomind’s Gene-Drug Reference Guide, “Who Should Get Tested” has been updated, making...

A recently published report details the experience of Indiana University School of Medicine, who recently...

We understand your practice is busy, so we've developed a communication guide to save you time explaining the benefits of genetic testing to your patients.

The National Healthcare Safety Network (NHSN) has previously defined...

Unlike lateral flow devices, the QUIK CHEK™ device upflow technology is designed specifically for fecal sample testing...

We’ve developed this new free guide to help you save time and minimize the risks of side effects, treatment failure and drug-drug interactions.

Join Genomind and guest speaker, Dr. Joseph F. Goldberg, for a video presentation on the utilization of pharmacogenomics

A recent article in MLO noted that C. difficile causes 5-15% of hospital-acquired diarrhoeas and a growing number of community-acquired diarrhoeas.

Pneumonia is a leading infectious cause of hospitalization and death among patients of all ages worldwide and Streptococcus pneumoniae and Legionella pneumophila...